For pet use
[Veterinary Drug Name]
Generic name: Flunixin Meglumine Injection
Trade name:
English name: Flunixin Meglumine Injection
Pinyin: Funixin Pujia’an Zhusheye
[Main Ingredients] Flunixin meglumine
[Description] This drug is of colorless or light yellow transparent liquid.
[Pharmacological Action] As a potent cyclooxygenase inhibitor, flunixin meglumine has analgesic, antipyretic, anti-inflammatory, and anti-rheumatic effects. The analgesic effect refers to blocking the transmission of pain impulses by the inhibition of the synthesis of peripheral prostaglandins or their pain sensitizers, or their combined action. The anti-inflammatory effect of peripheral tissues may be caused by inhibiting cyclooxygenase, reducing the formation of prostaglandin precursors, and inhibiting other mediators to induce local inflammatory responses. Flunixin meglumine may also improve the hemodynamics in animals with septic shock.
[Drug Interaction] (1) Flunixin meglumine should not be used concurrently with other nonsteroidal anti-inflammatory drugs as it may exacerbate gastrointestinal toxic and side effects, such as ulcers and bleeding.
(2) Due to the high binding rate of plasma proteins, when used in combination with other drugs, flunixin meglumine may displace other drugs that bind to plasma proteins or be replaced by other drugs, resulting in enhanced effects and even toxicity of the displaced drugs.
[Function and Use] Antipyretic and analgesic anti-inflammatory drug, for the treatment of small animal fever, inflammatory diseases, muscle pain, and soft tissue pain.
[Dosage and Administration] On the basis of flunixin. Intramuscular or intravenous injection: 1-2 mg/time per 1 kg of body weight for dogs and cats, administered once or twice a day for a treatment duration not exceeding 5 days. Alternatively, follow the veterinarian’s instructions.
[Adverse Reaction] Intramuscular injection may cause local irritation. Prolonged use of high doses of this drug may lead to gastric ulcers and kidney damage in animals.
[Precautions] (1) This drug should be used with caution in animals with gastrointestinal ulcers.
(2) This drug should not be used concurrently with other nonsteroidal anti-inflammatory drugs.
[Withdrawal Period] It is not required.
[Specification] 2ml : 10mg on the basis of C14H11F3N2O2
[Package] 2ml/pc × 10 pcs/box × 100 boxes/carton
[Storage] It should be kept out of light and tightly sealed for storage.
[Shelf Life] 2 years
[Production License No.] (2022) SYSCZZ No. 08019
[GMP Certificate No.] (2022) SY GMP ZZ No. 08010
Approval No.] SYZ No. 080192409
[Executive Standard] Volume I of Veterinary Pharmacopoeia of the People’s Republic of China (2020 Edition)
